Skip to main content
. 2015 Jul 4;17(6):473–480. doi: 10.1016/j.neo.2015.05.001

Table 1.

Validation of Selected Genes In Vivo in the RAG2 KO Mouse Model

Summary of Individual shRNA knock down (KD) Data
Treatment Arm Tumor Take Rate
Untreated 6/6
Empty vector (pLKO) 6/8
CAIX-shRNA1 0/8
CAIX-shRNA2 0/8
MCT4-shRNA1 0/8
MCT4-shRNA2 0/8
xCT-shRNA1 0/8
xCT-shRNA2 0/8

Tumor take rate of the primary pancreatic tumor cells (PDX15) expressing shRNAs targeting CAIX (shRNA1 and shRNA2), xCT (shRNA1 and shRNA2), MCT4 (shRNA1 and shRNA2), empty vector (pLKO), and untreated control.